Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery (GOSAFE)
GOSAFE Study Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery An International Prospective Audit to Evaluate Postoperative Functional Outcomes and Quality of Life After Cancer Surgery in Geriatric Patients
Multicenter, international, prospective, observational study, designed to evaluate the postoperative results in terms of quality of life and functional recovery of elderly patients after major cancer surgery.
The global expected duration of the study is 3 years, during which cancer patients over 70 years old undergoing major surgery will be evaluated before and after the surgical intervention, at 30 days, 3- and 6-months follow-up. The study is non-for-profit. Given the observational nature of the study, the original treatment plan, as designed by each individual recruiting centre, will not be altered or affected by the study inclusion. Inclusion in the study does not imply any deviation from the current standard of practice, and no change is expected to the perioperative treatment at any point. Patients will be only asked to complete simple screening/assessment tests.
Studieoversikt
Detaljert beskrivelse
GOSAFE study is a prospective international collaborative high-quality registry aiming to gain knowledge about postoperative outcomes in older cancer patients with a particular emphasis on QoL and FR. The target is to obtain meaningful data to assist clinicians in tailoring the care, avoiding under/over-treatment, providing robust data to identify new strategies to improve functional outcomes in older cancer patients.
Recruiting centers will collect data prospectively. Recruited patients will be followed for 6 months after their surgery.
The original treatment plan, as designed by each individual recruiting centre, will not be altered or affected by the study inclusion.
Centers should ensure that they would make every possible effort to include all consecutive eligible patients during the study period and provide completeness of data entry to ensure a 'real-life' study.
Patients both gender, both gender, aged ≥70, affected by solid malignancy undergoing elective major surgical procedures with curative or palliative intent are eligible.
Inclusion in the study does not imply any deviation from the current standard of practice, and no change is expected to the perioperative treatment at any point. Patients will be only asked to complete simple screening/assessment tests.
For every eligible patient, demographic data will be collected at baseline followed by a fast preoperative functional assessment. Data regarding surgical procedures and perioperative measures will be collected. Complications will be reported and graded according to Clavien-Dindo Classification. Three- and six-month follow up data will be collected after surgery within a range of 2 weeks from the due date.
The Full Analysis Set (FAS) consists of all registered patients. The primary endpoint will be measured for all registered subjects who fulfill preoperative and postoperative EQ VAS. Demographic and baseline patient characteristics will be summarized for all patients in the FAS. Continuous-scaled variables (e.g., age) will be summarized with means, medians, standard deviations, quartiles, and minimum and maximum values. Categorical variables (e.g., sex) will be summarized using patient counts and percentages. Study endpoints and variables will be evaluated using descriptive statistics, and the key figures of the distributions will be presented in tables. Univariate analyses will allow for a first overview of potentially influential factors.
Multiple linear regression models will be performed in order to evaluate predictors of functional recovery at 3 months and 6 months after surgery.
Exploratory subgroup analyses will be performed. Missing values will be replaced and estimated using multiple imputations. Furthermore, sensitivity analysis will be executed using complete-case analysis.
A sample size of 265 patients who completed pre and postoperative EQ VAS questionnaires will have a 90% power to detect an effect size of 0,2 between pre and post surgery ,using a paired t-test with a 0,05 two sided significance level.
Given a potential loss to follow-up (about 10%), uncompleted questionnaires (about 10%) and postoperative mortality (about 15%), the sample size will be increased to 350-400 patients (see ref 18 and 19).
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Florida
-
Weston, Florida, Forente stater, 33331
- Cleveland Clinic Florida
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02115
- Brigham and Women's Hospital
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- University of Pennsylvenia Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, Forente stater, 02908
- Roger William Medical Centre
-
-
-
-
-
Thessaloníki, Hellas, 54248
- Medical School, Aristotle University of Thessaloniki
-
-
-
-
-
Petah Tikva, Israel, 4592500
- Rabin Medical Center
-
-
-
-
-
Milano, Italia, 20162
- Ospedale Niguarda
-
Piacenza, Italia, 29121
- Ospedale di Piacenza
-
Vercelli, Italia, 13100
- Clinica S. Rita
-
-
Forli-Cesena
-
Forlì, Forli-Cesena, Italia, 47121
- Ospedale di Forlì
-
-
Lazio
-
Roma, Lazio, Italia, 00100
- Ospedale S. Andrea
-
-
Liguria
-
Genova, Liguria, Italia, 16121
- IRCCS Ospedale S. Martino Genova, Chirurgia Generale ad indirizzo oncologico
-
Genova, Liguria, Italia, 16121
- IRCCS Ospedale S. Martino Genova, Clinica Chirurgica 1
-
-
Milano
-
Rozzano, Milano, Italia, 20089
- Humanitas
-
-
Monza E Brianza
-
Desio, Monza E Brianza, Italia, 20039
- Ospedale di Desio
-
-
Perugia
-
Spoleto, Perugia, Italia, 06049
- Ospedale S. Matteo degli Infermi
-
-
Puglia
-
Bari, Puglia, Italia, 70121
- IstitutoTumori Giovanni Paolo II
-
-
Ravenna
-
Faenza, Ravenna, Italia, 48018
- General Surgery Unit
-
-
Rimini
-
Riccione, Rimini, Italia, 47838
- Ospedale di Riccione
-
-
-
-
-
Groningen, Nederland
- Groeningen University Hospital
-
-
-
-
-
Oslo, Norge
- Institute of Clinical Medicine
-
-
-
-
-
Kraków, Polen
- Jagiellonian University Medical College
-
-
-
-
-
Lisbon, Portugal
- General Surgery dept,Hospital Sao Francisco Xavier (CHLO)
-
Santiago do Cacém, Portugal, 7500
- Unidade Local de Saúde do Litoral Alentejano (ULSLA)
-
-
-
-
-
Alicante, Spania, 03001
- Universidad Miguel Hernández. Elche. Alicante
-
Valencia, Spania, 46700
- Hospital Universitario y Politécnico La Fe
-
-
-
-
-
Liverpool, Storbritannia
- Dept. of Surgical Oncology - St. Helens Hospital of Liverpool
-
Manchester, Storbritannia
- Manchester Royal Infirmary, University of Manchester
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- All consecutive patients, both gender, aged ≥70
- Patients affected by solid malignancy
- Patients undergoing elective major surgical procedures with curative or palliative intent (all major procedures including any resection, for any cancer, via any operative approach, open, laparoscopic, robotic, etc…)
- Informed consent obtainment
Exclusion Criteria:
- Patients undergoing emergent/urgent surgical procedures
- Planned hospital stay less than 48 hours
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Group 1
Elderly patiences with solid malignancy
|
Quality of Life and Functional recovery questionnaires
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Quality of Life (QoL)
Tidsramme: 6 months
|
To evaluate the effects of surgery on patients' life perception by comparing pre- and post-operative QoL in elderly patients undergoing major surgery for solid malignancies using a self-reported Quality of Life assessment tool
|
6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Functional recovery (FR)
Tidsramme: 6 months
|
To evaluate FR in terms of nutritional status, restoration of daily activities and cognitive status
|
6 months
|
|
Morbidity
Tidsramme: 6 months
|
To evaluate 3 and 6 months postoperative morbidity
|
6 months
|
|
Mortality
Tidsramme: 6 months
|
To evaluate 3 and 6 months postoperative mortality
|
6 months
|
|
Prognostic factors
Tidsramme: 6 months
|
To obtain prognostic factors for postoperative functional recovery which will assist in the treatment planning /intervention of future elderly patients who are offered surgery for cancer
|
6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Giampaolo Giampaolo, MD, AUSL Romagna
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- GOSAFE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .